|
Pharma execs, upset by Trump's drug pricing executive orders, refuse White House meeting
|
|
FiercePharma
|
|
At issue is the president's order linking drug prices in Medicare to lower prices abroad, which the industry argues will import socialist price controls into America's healthcare system. Trump on Friday gave the industry a month to propose an alternative, but a spokeswoman for industry trade group PhRMA told Fierce Pharma the industry's "sole focus is figuring out a way to beat COVID-19."
|
|
|